- Home
- WAFU vs PTIX Comparison
WAFU vs PTIX Comparison
Compare WAFU & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- PTIX
- Stock Information
- Founded
- WAFU 1999
- PTIX 1994
- Country
- WAFU China
- PTIX United States
- Employees
- WAFU N/A
- PTIX N/A
- Industry
- WAFU Other Consumer Services
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- PTIX Health Care
- Exchange
- WAFU Nasdaq
- PTIX Nasdaq
- Market Cap
- WAFU 6.5M
- PTIX 6.3M
- IPO Year
- WAFU 2019
- PTIX 2016
- Fundamental
- Price
- WAFU N/A
- PTIX $3.42
- Analyst Decision
- WAFU
- PTIX
- Analyst Count
- WAFU 0
- PTIX 0
- Target Price
- WAFU N/A
- PTIX N/A
- AVG Volume (30 Days)
- WAFU 263.8K
- PTIX 104.7K
- Earning Date
- WAFU 01-01-0001
- PTIX 11-13-2025
- Dividend Yield
- WAFU N/A
- PTIX N/A
- EPS Growth
- WAFU N/A
- PTIX N/A
- EPS
- WAFU N/A
- PTIX N/A
- Revenue
- WAFU $6,186,645.00
- PTIX N/A
- Revenue This Year
- WAFU N/A
- PTIX N/A
- Revenue Next Year
- WAFU N/A
- PTIX N/A
- P/E Ratio
- WAFU N/A
- PTIX N/A
- Revenue Growth
- WAFU N/A
- PTIX N/A
- 52 Week Low
- WAFU $1.22
- PTIX $2.25
- 52 Week High
- WAFU $7.49
- PTIX $15.26
- Technical
- Relative Strength Index (RSI)
- WAFU 63.32
- PTIX 44.43
- Support Level
- WAFU $1.92
- PTIX $3.22
- Resistance Level
- WAFU $2.17
- PTIX $3.53
- Average True Range (ATR)
- WAFU 0.13
- PTIX 0.28
- MACD
- WAFU 0.01
- PTIX -0.09
- Stochastic Oscillator
- WAFU 58.00
- PTIX 8.27
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.